Pharmacogenetics of breast cancer therapies
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference49 articles.
1. World Cancer Report;IARC,2008
2. Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial;Fisher;J Clin Oncol,1986
3. Aggressive adriamycin-containing regimen (PM-FAC) in estrogen receptor-negative disseminated breast cancer. Results of a Southwest Oncology Group trial;Mortimer;Cancer,1985
4. Liu S, Chia S, Mehl E. Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients. Breast Cancer Res Treat. 2009 Feb 10 [Epub ahead of print].
5. HER2 as a prognostic factor in breast cancer;Menard;Oncology,2001
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A functional gene module identification algorithm in gene expression data based on genetic algorithm and gene ontology;BMC Genomics;2023-02-17
2. Pharmacogenetics of Breast Cancer Treatments: A Sub-Saharan Africa Perspective;Pharmacogenomics and Personalized Medicine;2022-06
3. Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients;Frontiers in Pharmacology;2021-11-25
4. SNPs and taxane toxicity in breast cancer patients;Pharmacogenomics;2014-11
5. Synergy of novel coumarin derivatives and tamoxifen in blocking growth and inducing apoptosis of breast cancer cells;Macedonian Pharmaceutical Bulletin;2014
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3